Vantin: Advanced Cephalosporin Therapy for Bacterial Infections
Vantin
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.70 | $81.00 (0%) | π Add to cart |
| 60 | $2.23 | $162.00 $134.00 (17%) | π Add to cart |
| 90 | $2.08 | $243.00 $187.00 (23%) | π Add to cart |
| 120 | $2.01 | $324.00 $241.00 (26%) | π Add to cart |
| 180 | $1.93 | $486.00 $347.00 (29%) | π Add to cart |
| 270 | $1.88
Best per pill | $729.00 $507.00 (30%) | π Add to cart |
| Product dosage: 200mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $4.10 | $123.00 (0%) | π Add to cart |
| 60 | $3.40 | $246.00 $204.00 (17%) | π Add to cart |
| 90 | $3.17 | $369.00 $285.00 (23%) | π Add to cart |
| 120 | $3.05 | $492.00 $366.00 (26%) | π Add to cart |
| 180 | $2.94 | $738.00 $529.00 (28%) | π Add to cart |
| 270 | $2.86
Best per pill | $1107.00 $771.00 (30%) | π Add to cart |
Synonyms
| |||
Vantin (cefpodoxime proxetil) is an oral, third-generation cephalosporin antibiotic designed to treat a wide spectrum of bacterial infections. It functions by inhibiting bacterial cell wall synthesis, leading to the eradication of susceptible pathogens. This medication is prescribed for conditions including community-acquired pneumonia, acute bacterial exacerbations of chronic bronchitis, uncomplicated skin and skin structure infections, acute otitis media, pharyngitis, tonsillitis, and uncomplicated urinary tract infections. Its broad-spectrum activity and favorable pharmacokinetic profile make it a reliable choice for clinicians aiming for effective microbial eradication with a well-tolerated oral regimen.
Features
- Active ingredient: Cefpodoxime proxetil, a prodrug hydrolyzed to active cefpodoxime
- Available in tablet and oral suspension formulations
- Broad-spectrum activity against Gram-positive and Gram-negative bacteria
- Dosage forms: 100 mg and 200 mg film-coated tablets; 50 mg/5 mL and 100 mg/5 mL granules for oral suspension
- Typically administered twice daily, with or without food (though absorption is enhanced with food)
- Excreted primarily unchanged in the urine
Benefits
- Effectively treats a wide range of common bacterial infections, reducing symptom duration and complication risks
- Oral bioavailability allows for convenient outpatient treatment, potentially avoiding hospitalization
- Demonstrated efficacy against key pathogens including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Escherichia coli
- Generally well-tolerated profile with a low incidence of severe adverse effects compared to some alternative antibiotics
- Suitable for both adult and pediatric populations (aged 2 months and older), offering flexible dosing
Common use
Vantin is indicated for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms. Common uses include respiratory tract infections such as community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis. It is also employed for uncomplicated skin and skin structure infections, acute otitis media in pediatric patients, and streptococcal pharyngitis/tonsillitis. Additionally, it is prescribed for uncomplicated urinary tract infections, including cystitis, caused by E. coli, Klebsiella pneumoniae, Proteus mirabilis, or Staphylococcus saprophyticus.
Dosage and direction
Dosage varies based on infection type, severity, patient age, and renal function. For adults and adolescents (aged 12 years and older), typical doses range from 200 mg to 400 mg daily, divided into two administrations. For pediatric patients, dosage is based on body weight (5 mg/kg to 10 mg/kg per day, divided into two doses). The oral suspension must be shaken well before each use. Tablets should be swallowed whole; the suspension should be measured with a calibrated dosing device. Administration with food may enhance absorption and reduce gastrointestinal upset. Dosage adjustment is recommended in patients with renal impairment (creatinine clearance <30 mL/min).
Precautions
Use with caution in patients with a history of gastrointestinal disease, particularly colitis. Antibiotics, including Vantin, may cause overgrowth of nonsusceptible organisms; monitor for superinfection. Prolonged use may result in fungal or bacterial superinfection. Use in pregnancy only if clearly needed; it should be used during lactation only if the potential benefit justifies the potential risk to the infant. Caution is advised in patients with known hypersensitivity to penicillins or other beta-lactam antibiotics due to potential cross-reactivity.
Contraindications
Vantin is contraindicated in patients with known hypersensitivity to cefpodoxime, other cephalosporins, or any component of the formulation. It should not be used in patients who have experienced anaphylactic reactions to penicillins or other beta-lactam antibiotics.
Possible side effect
Common adverse reactions include diarrhea, nausea, abdominal pain, vaginal moniliasis or vaginitis, headache, and skin rashes. Less frequently, vomiting, flatulence, dizziness, and fatigue may occur. Serious but rare side effects include pseudomembranous colitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, anaphylaxis, hemolytic anemia, and hepatic dysfunction. Patients should discontinue use and seek medical attention if severe diarrhea, rash, or signs of hypersensitivity develop.
Drug interaction
Probenecid may inhibit renal excretion of cefpodoxime, increasing serum levels. Antacids containing aluminum or magnesium may reduce absorption; administer Vantin at least 2 hours before or after such agents. Concurrent use with potent diuretics may affect renal function and necessitate dosage adjustment. Caution is advised with other nephrotoxic drugs. No clinically significant interactions with oral contraceptives have been reported, but patients should be advised of potential reduced efficacy and consider backup contraception.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next dose, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended.
Overdose
Symptoms of overdose may include nausea, vomiting, epigastric distress, and diarrhea. In cases of significant overdose, hemodialysis may aid in removal of the drug. Treatment is supportive and symptomatic; there is no specific antidote.
Storage
Store tablets at controlled room temperature (20Β°C to 25Β°C). Keep in a tightly closed container. The oral suspension, once reconstituted, should be stored in the refrigerator (2Β°C to 8Β°C) and discarded after 14 days. Do not freeze. Keep out of reach of children and protect from light and moisture.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations and to address any health concerns or before starting any new medication. Do not disregard professional medical advice or delay seeking it based on content provided here.
Reviews
Clinical studies and post-marketing surveillance indicate that Vantin is generally effective and well-tolerated. In trials for respiratory tract infections, clinical cure rates exceeded 85% in compliant patients. Pediatric studies for acute otitis media demonstrated efficacy comparable to other cephalosporins. Some users report gastrointestinal discomfort, but severe adverse events are rare. Healthcare providers often note its convenience for outpatient management due to twice-daily dosing and broad spectrum.